In Canada, the US and Europe, stroke is the leading cause of long term adult disability
and the 3rd leading cause of death. Activation of caspase-6 (casp6) in response to
ischemia-induced injury has been observed in several rodent models of ischemia. In
addition, activated casp6 has been observed in post-mortem tissue from brains of patients
who died following ischemic stroke. Importantly, mice with a targeted deletion of
casp6 demonstrate reduced stroke injury and improved sensorimotor abilities. These
data provide important validation for the activation of casp6 as critical step in
the pathogenesis of stroke however important details of the hierarchy of caspase activation
events has been lacking. There is strong evidence to support a critical role for NMDA
receptor-mediated excitotoxicity as a mechanism underlying neuronal damage post stroke.
Inappropriate caspase activation in stroke could result from increases in intracellular
calcium levels due to excitotoxic stress and lead to generation of active proteolytic
fragments as a result of caspase substrate proteolysis. Using the well-characterized
in vitro model of stroke (rat primary cortical neurons ± NMDA) we demonstrate that at the early time point post NMDA (1h) no increase in levels
of LDH (cell death) is observed. However at 24h a significant increase in cell death
is detected (ANOVA p < 0.0001). Assessment of caspase mRNA levels demonstrates that increased casp6 mRNA
is observed at 1h and 24hs post NMDA (ANOVA p = 0.016), casp3 mRNA is significantly increased at 24h post NMDA (ANOVA p = 0.03) whereas no differences in casp8 or casp9 mRNA levels were observed. Increased
casp6 activity post NMDA was also detected (ANOVA p = 0.055, post hoc 0h vs. 1h, p < 0.05). Preliminary data also shows that cleavage of the novel casp6 substrate, STK3,
a proapoptotic kinase, and the casp6 substrate huntingtin [neuroprotective protein],
occurs early and prior to cell death. These data provide a clear link between excitotoxicity
and proteolysis and suggest that activation of casp6 is an early event in the pathogenesis
of stroke.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Autonomic Neuroscience: Basic and ClinicalAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
Article info
Publication history
Received:
May 15,
2013
Identification
Copyright
© 2013 Published by Elsevier Inc.